As shown here, PI3K/AKT signaling is further enhanced by loss of PTEN and PIPP over and above that observed with loss of an individual PI-phosphatase in breast cancer cells, and future screening for these changes in breast cancer cohorts may contribute to improved patient selection for treatments. The gene discussed is PIK3CA; the disease is breast carcinoma.